Dementia Medicine

Dementia medicine, particularly in the context of Alzheimer's Disease, focuses on various approaches to manage and treat cognitive decline. Current treatments primarily aim to alleviate symptoms rather than cure the underlying causes. Medications like cholinesterase inhibitors (such as donepezil, rivastigmine, and galantamine) are commonly prescribed to improve cognitive function by enhancing neurotransmitter activity in the brain. Another class of drugs, NMDA receptor antagonists like memantine, helps regulate glutamate activity, which is involved in learning and memory. Beyond pharmacological interventions, holistic approaches include cognitive stimulation therapy, physical exercise, and supportive care to enhance quality of life. Ongoing research aims to develop disease-modifying treatments that target the underlying pathology of Alzheimer's, addressing beta-amyloid plaques and tau tangles, to potentially slow disease progression.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Whatsapp